We are live on
!
Find out more
ATI
Act Two Investors Portfolio holdings
AUM
$453M
1-Year Est. Return
10.9%
This Fund
S&P 500
This Quarter
Est. Return
+10.42%
1 Year Est. Return
+10.9%
3 Year Est. Return
+52.85%
5 Year Est. Return
+67.7%
10 Year Est. Return
–
AUM
$512M
AUM Growth
+$57.9M
(+13%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
2.61%
Top 10 Holdings %
Top 10 Hldgs %
74.47%
Holding
37
New
3
Increased
18
Reduced
7
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$30.9M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$4.08M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$3.64M |
| 4 |
Northrop Grumman
NOC
|
+$1.61M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$25.4M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$3.91M |
| 3 |
Pfizer
PFE
|
+$3.59M |
| 4 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$3.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$355K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 24.79% |
| 2 | Technology | 21.95% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 9.25% |
Similar funds
FNB
VV
CFG
AA
MCM
TPWM
GSIAS
HIM
Act Two Investors's Q2 2021 Portfolio in Review
As of Q2 2021, Act Two Investors held 37 positions worth $512M, up 13% from $454M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Act Two Investors's Q2 2021 filing shows 3 new, 18 increased, 7 reduced and 3 closed positions. Its largest new stake was UnitedHealth: 77,386 shares worth $31M. The largest sale was Merck, an estimated $25.4M.
By sector, the portfolio is most concentrated in Communication Services at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
- Act Two Investors's largest Q2 2021 buy was UnitedHealth: 77,386 shares worth $31M.
- Act Two Investors added most to State Street Technology Select Sector SPDR ETF in Q2 2021, an estimated $4.08M increase.
- Act Two Investors's biggest Q2 2021 reduction was Pfizer, cutting an estimated $3.59M.
- Act Two Investors fully exited Merck in Q2 2021, selling an estimated $25.4M.
- Act Two Investors's ten largest holdings make up 74% of its $512M portfolio in Q2 2021.
- Act Two Investors opened 3 new positions and closed 3 in Q2 2021.
- Act Two Investors's portfolio value rose 13% quarter-over-quarter to $512M.
Based on Act Two Investors's 13F filing for Q2 2021, filed 12 Aug 2021.